Aldosterone-producing-adenoma (A-P-A): effect of pregnancy.
Serial measurements of plasma renin activity, plasma progesterone and urinary aldosterone were made before, during and after pregnancy in a patient from whom an A-P-A was later removed with cure of hypertension and hypokalemia. Despite 16-fold increases in urinary aldosterone during pregnancy, plasma renin activity levels became unsuppressed, and hypertension and hypokalemia were reversed. Increases in plasma progesterone or other steroids, competitively inhibiting the effects of aldosterone on its receptor, may explain remission of A-P-A and reversal of renin suppression during pregnancy. In a second patient, the features of primary aldosteronism appeared immediately after a pregnancy, and removal of an A-P-A cured hypertension and hypokalemia. A-P-A is more common in females and may appear following pregnancy. Urinary aldosterone was 6-fold higher after pregnancy than before. Thus, sex steroids may not only protect from hyperaldosteronism but may also stimulate growth of A-P-A's.
D000236:Adenoma / Q000097:blood / Q000150:complications / Q000378:metabolism*; D000310:Adrenal Gland Neoplasms / Q000097:blood / Q000150:complications / Q000378:metabolism*; D000328:Adult; D000450:Aldosterone / Q000378:metabolism* / Q000652:urine; D005260:Female; D006801:Humans; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000097:blood*; D011374:Progesterone / Q000097:blood; D012083:Renin / Q000097:blood
D000450:Aldosterone; D011374:Progesterone; D012083:Renin